><title>References</title><ref id="B1-ijms-18-02725"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lechartier</surname><given-names>B.</given-names></name><name><surname>Rybniker</surname><given-names>J.</given-names></name><name><surname>Zumla</surname><given-names>A.</given-names></name><name><surname>Cole</surname><given-names>S.T.</given-names></name></person-group><article-title>Tuberculosis drug discovery in the post-post-genomic era</article-title><source>EMBO Mol. Med.</source><year>2014</year><volume>6</volume><fpage>158</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1002/emmm.201201772</pub-id><?supplied-pmid 24401837?><pub-id pub-id-type="pmid">24401837</pub-id></element-citation></ref><ref id="B2-ijms-18-02725"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>K.</given-names></name><name><surname>Salgame</surname><given-names>P.</given-names></name></person-group><article-title>Host innate immune response to <italic>Mycobacterium tuberculosis</italic></article-title><source>J. Clin. Immunol.</source><year>2007</year><volume>27</volume><fpage>347</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1007/s10875-007-9084-0</pub-id><?supplied-pmid 17364232?><pub-id pub-id-type="pmid">17364232</pub-id></element-citation></ref><ref id="B3-ijms-18-02725"><label>3.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Global Tuberculosis Report, 2017</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/global_report/en/">http://www.who.int/tb/publications/global_report/en/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2017-09-18">(accessed on 18 September 2017)</date-in-citation></element-citation></ref><ref id="B4-ijms-18-02725"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Tato</surname><given-names>C.M.</given-names></name><name><surname>Muul</surname><given-names>L.</given-names></name><name><surname>Laurence</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>J.J.</given-names></name></person-group><article-title>Distinct regulation of interleukin-17 in human T helper lymphocytes</article-title><source>Arthritis Rheum.</source><year>2007</year><volume>56</volume><fpage>2936</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.1002/art.22866</pub-id><?supplied-pmid 17763419?><pub-id pub-id-type="pmid">17763419</pub-id></element-citation></ref><ref id="B5-ijms-18-02725"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>N.J.</given-names></name><name><surname>Boniface</surname><given-names>K.</given-names></name><name><surname>Chan</surname><given-names>J.R.</given-names></name><name><surname>McKenzie</surname><given-names>B.S.</given-names></name><name><surname>Blumenschein</surname><given-names>W.M.</given-names></name><name><surname>Mattson</surname><given-names>J.D.</given-names></name><name><surname>Basham</surname><given-names>B.</given-names></name><name><surname>Smith</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Morel</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Development, cytokine profile and function of human interleukin 17-producing helper T cells</article-title><source>Nat. Immunol.</source><year>2007</year><volume>8</volume><fpage>950</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1038/ni1497</pub-id><?supplied-pmid 17676044?><pub-id pub-id-type="pmid">17676044</pub-id></element-citation></ref><ref id="B6-ijms-18-02725"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coombes</surname><given-names>B.K.</given-names></name><name><surname>Valdez</surname><given-names>Y.</given-names></name><name><surname>Finlay</surname><given-names>B.B.</given-names></name></person-group><article-title>Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses</article-title><source>Curr. Biol.</source><year>2004</year><volume>14</volume><fpage>856</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.09.043</pub-id><?supplied-pmid 15458668?><pub-id pub-id-type="pmid">15458668</pub-id></element-citation></ref><ref id="B7-ijms-18-02725"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>A.</given-names></name><name><surname>Dancourt</surname><given-names>J.</given-names></name><name><surname>Mugo</surname><given-names>B.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>T.J.</given-names></name><name><surname>Isberg</surname><given-names>R.R.</given-names></name><name><surname>Melia</surname><given-names>T.J.</given-names></name><name><surname>Roy</surname><given-names>C.R.</given-names></name></person-group><article-title>The Legionella effector RavZ inhibits host autophagy through irreversible Atg8 deconjugation</article-title><source>Science</source><year>2012</year><volume>338</volume><fpage>1072</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1126/science.1227026</pub-id><?supplied-pmid 23112293?><pub-id pub-id-type="pmid">23112293</pub-id></element-citation></ref><ref id="B8-ijms-18-02725"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.T.</given-names></name><name><surname>Du</surname><given-names>F.</given-names></name><name><surname>Aroh</surname><given-names>C.</given-names></name><name><surname>Yan</surname><given-names>N.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.J.</given-names></name></person-group><article-title>Cyclic GMP-AMP Synthase is an innate immune sensor of HIV and other retroviruses</article-title><source>Science</source><year>2013</year><volume>341</volume><fpage>903</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1126/science.1240933</pub-id><?supplied-pmid 23929945?><pub-id pub-id-type="pmid">23929945</pub-id></element-citation></ref><ref id="B9-ijms-18-02725"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Z.J.</given-names></name></person-group><article-title>Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>786</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1126/science.1232458</pub-id><?supplied-pmid 23258413?><pub-id pub-id-type="pmid">23258413</pub-id></element-citation></ref><ref id="B10-ijms-18-02725"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tattoli</surname><given-names>I.</given-names></name><name><surname>Sorbara</surname><given-names>M.T.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Tooze</surname><given-names>S.A.</given-names></name><name><surname>Philpott</surname><given-names>D.J.</given-names></name><name><surname>Girardin</surname><given-names>S.E.</given-names></name></person-group><article-title><italic>Listeria</italic> phospholipases subvert host autophagic defenses by stalling pre-autophagosomal structures</article-title><source>EMBO J.</source><year>2013</year><volume>32</volume><fpage>3066</fpage><lpage>3078</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.234</pub-id><?supplied-pmid 24162724?><pub-id pub-id-type="pmid">24162724</pub-id></element-citation></ref><ref id="B11-ijms-18-02725"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019; Garra</surname><given-names>A.</given-names></name><name><surname>Redford</surname><given-names>P.S.</given-names></name><name><surname>McNab</surname><given-names>F.W.</given-names></name><name><surname>Bloom</surname><given-names>C.I.</given-names></name><name><surname>Wilkinson</surname><given-names>R.J.</given-names></name><name><surname>Berry</surname><given-names>M.P.</given-names></name></person-group><article-title>The immune response in tuberculosis</article-title><source>Annu. Rev. Immunol.</source><year>2013</year><volume>31</volume><fpage>475</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id><?supplied-pmid 23516984?><pub-id pub-id-type="pmid">23516984</pub-id></element-citation></ref><ref id="B12-ijms-18-02725"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremond</surname><given-names>C.M.</given-names></name><name><surname>Togbe</surname><given-names>D.</given-names></name><name><surname>Doz</surname><given-names>E.</given-names></name><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Vasseur</surname><given-names>V.</given-names></name><name><surname>Maillet</surname><given-names>I.</given-names></name><name><surname>Jacobs</surname><given-names>M.</given-names></name><name><surname>Ryffel</surname><given-names>B.</given-names></name><name><surname>Quesniaux</surname><given-names>V.F.</given-names></name></person-group><article-title>IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>J. Immunol.</source><year>2007</year><volume>179</volume><fpage>1178</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1178</pub-id><?supplied-pmid 17617611?><pub-id pub-id-type="pmid">17617611</pub-id></element-citation></ref><ref id="B13-ijms-18-02725"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M.P.</given-names></name><name><surname>Graham</surname><given-names>C.M.F.</given-names></name><name><surname>McNab</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S.A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Wilkinson</surname><given-names>K.A.</given-names></name><name><surname>Banchereau</surname><given-names>R.</given-names></name><name><surname>Skinner</surname><given-names>J.</given-names></name><name><surname>Wilkinson</surname><given-names>R.J.</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="B14-ijms-18-02725"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G.</given-names></name></person-group><article-title>Type I interferon: friend or foe?</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>2053</fpage><lpage>2063</lpage><pub-id pub-id-type="doi">10.1084/jem.20101664</pub-id><?supplied-pmid 20837696?><pub-id pub-id-type="pmid">20837696</pub-id></element-citation></ref><ref id="B15-ijms-18-02725"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>S.A.</given-names></name><name><surname>Johndrow</surname><given-names>J.E.</given-names></name><name><surname>Manzanillo</surname><given-names>P.</given-names></name><name><surname>Cox</surname><given-names>J.S.</given-names></name></person-group><article-title>The type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title><source>J. Immunol.</source><year>2006</year><volume>178</volume><fpage>3143</fpage><lpage>3152</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3143</pub-id></element-citation></ref><ref id="B16-ijms-18-02725"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Barczak</surname><given-names>A.K.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Murray</surname><given-names>P.J.</given-names></name><name><surname>Barry</surname><given-names>C.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group><article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-STAT pathway</article-title><source>J. Interferon Cytokine Res.</source><year>2005</year><volume>25</volume><fpage>694</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1089/jir.2005.25.694</pub-id><?supplied-pmid 16318583?><pub-id pub-id-type="pmid">16318583</pub-id></element-citation></ref><ref id="B17-ijms-18-02725"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Stockinger</surname><given-names>S.</given-names></name></person-group><article-title>The yin and yang of type I interferon activity in bacterial infection</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>9</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nri1684</pub-id><?supplied-pmid 16110316?><pub-id pub-id-type="pmid">16110316</pub-id></element-citation></ref><ref id="B18-ijms-18-02725"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname><given-names>L.C.</given-names></name></person-group><article-title>Mechanisms of type I- and type II-interferon-mediated signaling</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>5</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/nri1604</pub-id><?supplied-pmid 15864272?><pub-id pub-id-type="pmid">15864272</pub-id></element-citation></ref><ref id="B19-ijms-18-02725"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Baig</surname><given-names>E.</given-names></name><name><surname>Fish</surname><given-names>E.N.</given-names></name></person-group><article-title>Diversity and relatedness among the type I interferons</article-title><source>J. Interferon Cytokine Res.</source><year>2004</year><volume>24</volume><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1089/jir.2004.24.687</pub-id><?supplied-pmid 15684736?><pub-id pub-id-type="pmid">15684736</pub-id></element-citation></ref><ref id="B20-ijms-18-02725"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Weerd</surname><given-names>N.A.</given-names></name><name><surname>Samarajiwa</surname><given-names>S.A.</given-names></name><name><surname>Hertzog</surname><given-names>P.J.</given-names></name></person-group><article-title>Type I interferon receptors: Biochemistry and biological functions</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>20053</fpage><lpage>20057</lpage><pub-id pub-id-type="doi">10.1074/jbc.R700006200</pub-id><?supplied-pmid 17502368?><pub-id pub-id-type="pmid">17502368</pub-id></element-citation></ref><ref id="B21-ijms-18-02725"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname><given-names>P.</given-names></name><name><surname>Kindsvogel</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Henderson</surname><given-names>K.</given-names></name><name><surname>Schlutsmeyer</surname><given-names>S.</given-names></name><name><surname>Whitmore</surname><given-names>T.E.</given-names></name><name><surname>Kuestner</surname><given-names>R.</given-names></name><name><surname>Garrigues</surname><given-names>U.</given-names></name><name><surname>Birks</surname><given-names>C.</given-names></name><name><surname>Roraback</surname><given-names>J.</given-names></name><etal/></person-group><article-title>IL-28, IL-29 and their class II cytokine receptor IL-28R</article-title><source>Nat. Immunol.</source><year>2003</year><volume>4</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/ni873</pub-id><?supplied-pmid 12469119?><pub-id pub-id-type="pmid">12469119</pub-id></element-citation></ref><ref id="B22-ijms-18-02725"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>B.A.</given-names></name><name><surname>Sheppard</surname><given-names>P.O.</given-names></name><name><surname>O&#x02019;Hara</surname><given-names>P.J.</given-names></name></person-group><article-title>The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-&#x003bb; family</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><elocation-id>e4933</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0004933</pub-id><?supplied-pmid 19300512?><pub-id pub-id-type="pmid">19300512</pub-id></element-citation></ref><ref id="B23-ijms-18-02725"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokunina-Olsson</surname><given-names>L.</given-names></name><name><surname>Muchmore</surname><given-names>B.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Pfeiffer</surname><given-names>R.M.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Dickensheets</surname><given-names>H.</given-names></name><name><surname>Hergott</surname><given-names>D.</given-names></name><name><surname>Porter-Gill</surname><given-names>P.</given-names></name><name><surname>Mumy</surname><given-names>A.</given-names></name><name><surname>Kohaar</surname><given-names>I.</given-names></name><etal/></person-group><article-title>A variant upstream of <italic>IFNL3</italic> (<italic>IL28B</italic>) creating a new interferon gene <italic>IFNL4</italic> is associated with impaired clearance of hepatitis C virus</article-title><source>Nat. Genet.</source><year>2013</year><volume>45</volume><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1038/ng.2521</pub-id><?supplied-pmid 23291588?><pub-id pub-id-type="pmid">23291588</pub-id></element-citation></ref><ref id="B24-ijms-18-02725"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumoutier</surname><given-names>L.</given-names></name><name><surname>Tounsi</surname><given-names>A.</given-names></name><name><surname>Michiels</surname><given-names>T.</given-names></name><name><surname>Sommereyns</surname><given-names>C.</given-names></name><name><surname>Kotenko</surname><given-names>S.V.</given-names></name><name><surname>Renauld</surname><given-names>J.C.</given-names></name></person-group><article-title>Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-&#x003bb;1: Similarities with type I interferon signaling</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>32269</fpage><lpage>32274</lpage><pub-id pub-id-type="doi">10.1074/jbc.M404789200</pub-id><?supplied-pmid 15166220?><pub-id pub-id-type="pmid">15166220</pub-id></element-citation></ref><ref id="B25-ijms-18-02725"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmar</surname><given-names>S.</given-names></name><name><surname>Platanias</surname><given-names>L.C.</given-names></name></person-group><article-title>Interferons: Mechanisms of action and clinical applications</article-title><source>Curr. Opin. Oncol.</source><year>2003</year><volume>15</volume><fpage>431</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1097/00001622-200311000-00005</pub-id><?supplied-pmid 14624225?><pub-id pub-id-type="pmid">14624225</pub-id></element-citation></ref><ref id="B26-ijms-18-02725"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdan</surname><given-names>C.</given-names></name></person-group><article-title>The function of type I interferons in antimicrobial immunity</article-title><source>Curr. Opin. Immunol.</source><year>2000</year><volume>12</volume><fpage>419</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(00)00111-4</pub-id><pub-id pub-id-type="pmid">10899033</pub-id></element-citation></ref><ref id="B27-ijms-18-02725"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T.</given-names></name><name><surname>Stockinger</surname><given-names>S.</given-names></name><name><surname>Karaghiosoff</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Kovarik</surname><given-names>P.</given-names></name></person-group><article-title>Interferons and STATs in innate immunity to microorganisms</article-title><source>J. Clin. Investig.</source><year>2002</year><volume>109</volume><fpage>1271</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1172/JCI0215770</pub-id><?supplied-pmid 12021240?><pub-id pub-id-type="pmid">12021240</pub-id></element-citation></ref><ref id="B28-ijms-18-02725"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.J.</given-names></name><name><surname>Reichner</surname><given-names>J.S.</given-names></name><name><surname>Mastrofrancesco</surname><given-names>B.</given-names></name><name><surname>Henry</surname><given-names>W.L.</given-names></name><name><surname>Albina</surname><given-names>J.E.</given-names></name></person-group><article-title>Prostaglandin E2 suppresses lipopolysaccharide stimulated IFN-&#x003b2; production</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>2125</fpage><lpage>2131</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2125</pub-id><?supplied-pmid 18250418?><pub-id pub-id-type="pmid">18250418</pub-id></element-citation></ref><ref id="B29-ijms-18-02725"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bon</surname><given-names>A.L.</given-names></name><name><surname>Thompson</surname><given-names>C.</given-names></name><name><surname>Durand</surname><given-names>E.K.V.</given-names></name><name><surname>Rossmann</surname><given-names>C.</given-names></name><name><surname>Kalinke</surname><given-names>U.</given-names></name><name><surname>David</surname><given-names>F.</given-names></name></person-group><article-title>Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN</article-title><source>J. Immunol.</source><year>2006</year><volume>176</volume><fpage>2074</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2074</pub-id><?supplied-pmid 16455962?><pub-id pub-id-type="pmid">16455962</pub-id></element-citation></ref><ref id="B30-ijms-18-02725"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>D.B.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Type I interferons in host defense</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.007</pub-id><?supplied-pmid 16979569?><pub-id pub-id-type="pmid">16979569</pub-id></element-citation></ref><ref id="B31-ijms-18-02725"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>S.</given-names></name><name><surname>Langer</surname><given-names>J.A.</given-names></name><name><surname>Zoon</surname><given-names>K.C.</given-names></name><name><surname>Samuel</surname><given-names>C.E.</given-names></name></person-group><article-title>Interferons and their actions</article-title><source>Annu. Rev. Biochem.</source><year>1987</year><volume>56</volume><fpage>727</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.56.070187.003455</pub-id><?supplied-pmid 2441659?><pub-id pub-id-type="pmid">2441659</pub-id></element-citation></ref><ref id="B32-ijms-18-02725"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoreschi</surname><given-names>K.</given-names></name><name><surname>Laurence</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>J.J.</given-names></name></person-group><article-title>Janus kinases in immune cell signaling</article-title><source>Immunol. Rev.</source><year>2009</year><volume>228</volume><fpage>273</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00754.x</pub-id><?supplied-pmid 19290934?><pub-id pub-id-type="pmid">19290934</pub-id></element-citation></ref><ref id="B33-ijms-18-02725"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McComb</surname><given-names>S.</given-names></name><name><surname>Erin</surname><given-names>C.</given-names></name><name><surname>Alturki</surname><given-names>A.N.</given-names></name><name><surname>Joseph</surname><given-names>J.</given-names></name><name><surname>Shutinoski</surname><given-names>B.</given-names></name><name><surname>Startek</surname><given-names>J.B.</given-names></name><name><surname>Gamero</surname><given-names>A.M.</given-names></name><name><surname>Mossman</surname><given-names>K.L.</given-names></name><name><surname>Sad</surname><given-names>S.</given-names></name></person-group><article-title>Type-I interferon signaling through ISGF3 complex is required for sustained RIP3 activation and necroptosis in macrophages</article-title><source>PNAS</source><year>2014</year><volume>111</volume><fpage>E3206</fpage><lpage>E3213</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407068111</pub-id><?supplied-pmid 25049377?><pub-id pub-id-type="pmid">25049377</pub-id></element-citation></ref><ref id="B34-ijms-18-02725"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghislain</surname><given-names>J.J.</given-names></name><name><surname>Wong</surname><given-names>T.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Fish</surname><given-names>E.N.</given-names></name></person-group><article-title>The interferon-inducible STAT2: STAT1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes</article-title><source>J. Interferon Cytokine Res.</source><year>2001</year><volume>21</volume><fpage>379</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1089/107999001750277853</pub-id><?supplied-pmid 11440635?><pub-id pub-id-type="pmid">11440635</pub-id></element-citation></ref><ref id="B35-ijms-18-02725"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brierley</surname><given-names>M.M.</given-names></name><name><surname>Fish</surname><given-names>E.N.</given-names></name></person-group><article-title>Functional relevance of the conserved DNA-binding domain of STAT2</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>13029</fpage><lpage>13036</lpage><pub-id pub-id-type="doi">10.1074/jbc.M500426200</pub-id><?supplied-pmid 15668228?><pub-id pub-id-type="pmid">15668228</pub-id></element-citation></ref><ref id="B36-ijms-18-02725"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masumi</surname><given-names>A.</given-names></name><name><surname>Ozato</surname><given-names>K.</given-names></name></person-group><article-title>Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>20973</fpage><lpage>20980</lpage><pub-id pub-id-type="doi">10.1074/jbc.M101707200</pub-id><?supplied-pmid 11304541?><pub-id pub-id-type="pmid">11304541</pub-id></element-citation></ref><ref id="B37-ijms-18-02725"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meraro</surname><given-names>D.</given-names></name><name><surname>Gleit-Kielmanowicz</surname><given-names>M.</given-names></name><name><surname>Hauser</surname><given-names>H.</given-names></name><name><surname>Levi</surname><given-names>B.Z.</given-names></name></person-group><article-title>IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: Characterization of a new subtype of IFN-stimulated response element</article-title><source>J. Immunol.</source><year>2002</year><volume>168</volume><fpage>6224</fpage><lpage>6231</lpage><?supplied-pmid 12055236?><pub-id pub-id-type="pmid">12055236</pub-id></element-citation></ref><ref id="B38-ijms-18-02725"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mowen</surname><given-names>K.A.</given-names></name><name><surname>Zhu</surname><given-names>J.W.</given-names></name><name><surname>Schurter</surname><given-names>B.T.</given-names></name><name><surname>Shuai</surname><given-names>K.</given-names></name><name><surname>Herschman</surname><given-names>H.R.</given-names></name><name><surname>David</surname><given-names>M.</given-names></name></person-group><article-title>Methylation of STAT1 modulates IFN&#x003b1;/&#x003b2;-induced transcription</article-title><source>Cell</source><year>2001</year><volume>104</volume><fpage>731</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00269-0</pub-id><pub-id pub-id-type="pmid">11257227</pub-id></element-citation></ref><ref id="B39-ijms-18-02725"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenner</surname><given-names>J.E.</given-names></name><name><surname>Starr</surname><given-names>R.</given-names></name><name><surname>Cornish</surname><given-names>A.L.</given-names></name><name><surname>Zhang</surname><given-names>J.G.</given-names></name><name><surname>Metcalf</surname><given-names>D.</given-names></name><name><surname>Schreiber</surname><given-names>R.D.</given-names></name><name><surname>Sheehan</surname><given-names>J.</given-names></name><name><surname>Hilton</surname><given-names>K.D.</given-names></name><name><surname>Alexander</surname><given-names>W.S.</given-names></name><name><surname>Hertzog</surname><given-names>P.J.</given-names></name></person-group><article-title>Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity</article-title><source>Nat. Immunol.</source><year>2006</year><volume>7</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/ni1287</pub-id><?supplied-pmid 16311601?><pub-id pub-id-type="pmid">16311601</pub-id></element-citation></ref><ref id="B40-ijms-18-02725"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>H.E.</given-names></name><name><surname>Goelz</surname><given-names>S.</given-names></name><name><surname>Larner</surname><given-names>A.C.</given-names></name><name><surname>Neel</surname><given-names>B.G.</given-names></name></person-group><article-title>Differential regulation of the &#x003b1;/&#x003b2; interferon-stimulated Jak/STAT pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1</article-title><source>Mol. Cell Boil.</source><year>1995</year><volume>15</volume><fpage>7050</fpage><lpage>7058</lpage><pub-id pub-id-type="doi">10.1128/MCB.15.12.7050</pub-id></element-citation></ref><ref id="B41-ijms-18-02725"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>D.H.</given-names></name><name><surname>Feng</surname><given-names>G.S.</given-names></name></person-group><article-title>Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway</article-title><source>Mol. Cell Boil.</source><year>1999</year><volume>19</volume><fpage>2416</fpage><lpage>2424</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.3.2416</pub-id></element-citation></ref><ref id="B42-ijms-18-02725"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>M.P.</given-names></name><name><surname>Andersen</surname><given-names>J.N.</given-names></name><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Tremblay</surname><given-names>M.L.</given-names></name><name><surname>Horvath</surname><given-names>C.M.</given-names></name><name><surname>Parisien</surname><given-names>J.P.</given-names></name><name><surname>Salmeen</surname><given-names>A.</given-names></name><name><surname>Barford</surname><given-names>D.</given-names></name><name><surname>Tonks</surname><given-names>N.K.</given-names></name></person-group><article-title>TYK2 and Jak2 are substrates of protein-tyrosine phosphatase 1B</article-title><source>J. Boil. Chem.</source><year>2001</year><volume>276</volume><fpage>47771</fpage><lpage>47774</lpage><pub-id pub-id-type="doi">10.1074/jbc.C100583200</pub-id><?supplied-pmid 11694501?><pub-id pub-id-type="pmid">11694501</pub-id></element-citation></ref><ref id="B43-ijms-18-02725"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhova</surname><given-names>O.A.</given-names></name><name><surname>Kim</surname><given-names>K.I.</given-names></name><name><surname>Luo</surname><given-names>J.K.</given-names></name><name><surname>Zou</surname><given-names>W.</given-names></name><name><surname>Kumar</surname><given-names>K.G.</given-names></name><name><surname>Fuchs</surname><given-names>S.Y.</given-names></name><name><surname>Shuai</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>D.E.</given-names></name></person-group><article-title>UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity</article-title><source>EMBO J.</source><year>2006</year><volume>25</volume><fpage>2358</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601149</pub-id><?supplied-pmid 16710296?><pub-id pub-id-type="pmid">16710296</pub-id></element-citation></ref><ref id="B44-ijms-18-02725"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>R.M.</given-names></name><name><surname>Krutzik</surname><given-names>T.G.</given-names></name><name><surname>Montoya</surname><given-names>S.R.</given-names></name><name><surname>Schenk</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Komisopoulou</surname><given-names>D.J.</given-names></name><name><surname>Kelly-Scumpia</surname><given-names>E.</given-names></name><name><surname>Chun</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>R.</given-names></name><name><surname>Sarno</surname><given-names>S.S.</given-names></name><etal/></person-group><article-title>Type I interferon suppresses type II interferon-triggered human antimycobacterial responses</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>1448</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><?supplied-pmid 23449998?><pub-id pub-id-type="pmid">23449998</pub-id></element-citation></ref><ref id="B45-ijms-18-02725"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G.</given-names></name><name><surname>Mraun</surname><given-names>B.</given-names></name><name><surname>Staehli</surname><given-names>F.</given-names></name><name><surname>Tardivel</surname><given-names>A.</given-names></name><name><surname>Mattmann</surname><given-names>C.</given-names></name><name><surname>Farlik</surname><given-names>M.</given-names></name><name><surname>Decker</surname><given-names>T.</given-names></name><name><surname>Du Pasquier</surname><given-names>R.A.</given-names></name><name><surname>Romero</surname><given-names>P.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group><article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id><?supplied-pmid 21349431?><pub-id pub-id-type="pmid">21349431</pub-id></element-citation></ref><ref id="B46-ijms-18-02725"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K.D.</given-names></name><name><surname>Barber</surname><given-names>D.L.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>White</surname><given-names>S.D.</given-names></name><name><surname>Wilson</surname><given-names>M.S.</given-names></name><name><surname>Cheever</surname><given-names>A.</given-names></name></person-group><article-title>Caspase-1 independent IL-1&#x003b2; production is critical for host resistance to <italic>Mycobacterium tuberculosis</italic> and does not require TLR signaling in vivo</article-title><source>J. Immunol.</source><year>2010</year><volume>184</volume><fpage>3326</fpage><lpage>3330</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904189</pub-id><?supplied-pmid 20200276?><pub-id pub-id-type="pmid">20200276</pub-id></element-citation></ref><ref id="B47-ijms-18-02725"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A.</given-names></name><name><surname>Cardone</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>Kirschman</surname><given-names>K.D.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K.D.</given-names></name><name><surname>Myers</surname><given-names>T.G.</given-names></name><name><surname>Rabin</surname><given-names>R.L.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1&#x003b2; production in human macrophages</article-title><source>J. Immunol.</source><year>2011</year><volume>187</volume><fpage>2540</fpage><lpage>2547</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100926</pub-id><?supplied-pmid 21784976?><pub-id pub-id-type="pmid">21784976</pub-id></element-citation></ref><ref id="B48-ijms-18-02725"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molle</surname><given-names>C.</given-names></name><name><surname>Goldman</surname><given-names>M.</given-names></name><name><surname>Goriely</surname><given-names>S.</given-names></name></person-group><article-title>Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process</article-title><source>J. Immunol.</source><year>2010</year><volume>184</volume><fpage>1784</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902005</pub-id><?supplied-pmid 20083668?><pub-id pub-id-type="pmid">20083668</pub-id></element-citation></ref><ref id="B49-ijms-18-02725"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascanfroni</surname><given-names>I.D.</given-names></name><name><surname>Yeste</surname><given-names>A.</given-names></name><name><surname>Vieira</surname><given-names>S.M.</given-names></name><name><surname>Burns</surname><given-names>E.J.</given-names></name><name><surname>Patel</surname><given-names>B.</given-names></name><name><surname>Sloma</surname><given-names>I.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Mayo</surname><given-names>L.</given-names></name><name><surname>Ben-Hamo</surname><given-names>R.</given-names></name><name><surname>Efroni</surname><given-names>S.</given-names></name><etal/></person-group><article-title>IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39</article-title><source>Nat. Immunol.</source><year>2013</year><volume>14</volume><fpage>1054</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1038/ni.2695</pub-id><?supplied-pmid 23995234?><pub-id pub-id-type="pmid">23995234</pub-id></element-citation></ref><ref id="B50-ijms-18-02725"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V.</given-names></name><name><surname>Dirk</surname><given-names>G.</given-names></name><name><surname>Meyer-Morse</surname><given-names>N.</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M.</given-names></name><name><surname>Daniel</surname><given-names>A.</given-names></name></person-group><article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogene</italic></article-title><source>J. Exp. Med.</source><year>2004</year><volume>4</volume><fpage>527</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1084/jem.20040976</pub-id><?supplied-pmid 15302899?><pub-id pub-id-type="pmid">15302899</pub-id></element-citation></ref><ref id="B51-ijms-18-02725"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K.D.</given-names></name><name><surname>Andrade</surname><given-names>B.B.</given-names></name><name><surname>Barber</surname><given-names>D.L.</given-names></name><name><surname>Hieny</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>C.G.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><name><surname>Oland</surname><given-names>S.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group><article-title>Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id><?supplied-pmid 22195750?><pub-id pub-id-type="pmid">22195750</pub-id></element-citation></ref><ref id="B52-ijms-18-02725"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K.D.</given-names></name><name><surname>Andrade</surname><given-names>B.B.</given-names></name><name><surname>Oland</surname><given-names>S.D.</given-names></name><name><surname>Amaral</surname><given-names>E.P.</given-names></name><name><surname>Barber</surname><given-names>D.L.</given-names></name><name><surname>Gonzales</surname><given-names>J.</given-names></name><name><surname>Derrick</surname><given-names>S.C.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>N.P.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title><source>Nature</source><year>2014</year><volume>7507</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature13489</pub-id><?supplied-pmid 24990750?><pub-id pub-id-type="pmid">24990750</pub-id></element-citation></ref><ref id="B53-ijms-18-02725"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M.</given-names></name><name><surname>Humann</surname><given-names>J.</given-names></name><name><surname>Penheiter</surname><given-names>K.</given-names></name><name><surname>Andreasen</surname><given-names>K.</given-names></name><name><surname>Lenz</surname><given-names>L.L.</given-names></name></person-group><article-title>Induction of IFN-&#x003b1;&#x003b2; enables <italic>Listeria monocytogenes</italic> to suppress macrophage activation by IFN-&#x003b3;</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>327</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1084/jem.20091746</pub-id><?supplied-pmid 20123961?><pub-id pub-id-type="pmid">20123961</pub-id></element-citation></ref><ref id="B54-ijms-18-02725"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>C.A.</given-names></name></person-group><article-title>Interferons &#x003b1; and &#x003b2; as immune regulators&#x02014;A new look</article-title><source>Immunity</source><year>2001</year><volume>14</volume><fpage>661</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(01)00154-6</pub-id><pub-id pub-id-type="pmid">11420036</pub-id></element-citation></ref><ref id="B55-ijms-18-02725"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Chiu</surname><given-names>Y.H.</given-names></name><name><surname>Chen</surname><given-names>Z.J.</given-names></name></person-group><article-title>The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling</article-title><source>Mol. Cell</source><year>2014</year><volume>54</volume><fpage>289</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.040</pub-id><?supplied-pmid 24766893?><pub-id pub-id-type="pmid">24766893</pub-id></element-citation></ref><ref id="B56-ijms-18-02725"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Toll-like receptors and their crosstalk with other innate receptors in infection and immunity</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>637</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.006</pub-id><?supplied-pmid 21616434?><pub-id pub-id-type="pmid">21616434</pub-id></element-citation></ref><ref id="B57-ijms-18-02725"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loo</surname><given-names>Y.M.</given-names></name><name><surname>Gale</surname><given-names>M.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Immune signaling by RIG-I-like receptors</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>680</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.003</pub-id><?supplied-pmid 21616437?><pub-id pub-id-type="pmid">21616437</pub-id></element-citation></ref><ref id="B58-ijms-18-02725"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>T.H.M.</given-names></name><name><surname>Dass</surname><given-names>R.H.</given-names></name><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>M.M.</given-names></name><name><surname>Wong</surname><given-names>H.E.E.</given-names></name></person-group><article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis</article-title><source>PLoS ONE</source><year>2012</year><volume>9</volume><elocation-id>e45839</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0045839</pub-id><?supplied-pmid 23029268?><pub-id pub-id-type="pmid">23029268</pub-id></element-citation></ref><ref id="B59-ijms-18-02725"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhagen</surname><given-names>F.</given-names></name><name><surname>McFarland</surname><given-names>A.P.</given-names></name><name><surname>Rodriguez</surname><given-names>L.G.</given-names></name><name><surname>Tewary</surname><given-names>P.</given-names></name><name><surname>Jarret</surname><given-names>A.</given-names></name><name><surname>Savan</surname><given-names>R.</given-names></name><name><surname>Dennis</surname><given-names>M.K.</given-names></name></person-group><article-title>IRF-5 and NF-&#x003ba;B p50 co-regulate IFN-&#x003b2; and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells</article-title><source>Eur. J. Immunol.</source><year>2013</year><volume>43</volume><fpage>1896</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1002/eji.201242792</pub-id><?supplied-pmid 23616277?><pub-id pub-id-type="pmid">23616277</pub-id></element-citation></ref><ref id="B60-ijms-18-02725"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>W.M.</given-names></name><name><surname>Chevillotte</surname><given-names>M.D.</given-names></name><name><surname>Rice</surname><given-names>C.M.</given-names></name></person-group><article-title>Interferon-stimulated genes: A complex web of host defenses</article-title><source>Ann. Rev. Immunol.</source><year>2014</year><volume>32</volume><fpage>513</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id><?supplied-pmid 24555472?><pub-id pub-id-type="pmid">24555472</pub-id></element-citation></ref><ref id="B61-ijms-18-02725"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>J.R.</given-names></name><name><surname>Mee</surname><given-names>L.A.</given-names></name><name><surname>Sullivan</surname><given-names>B.M.</given-names></name><name><surname>Sheehan</surname><given-names>K.C.</given-names></name><name><surname>Welch</surname><given-names>M.</given-names></name><name><surname>Schreiber</surname><given-names>R.D.</given-names></name><name><surname>de la Torre</surname><given-names>J.C.</given-names></name><name><surname>Oldstone</surname><given-names>M.B.</given-names></name></person-group><article-title>LCMV infection is controlled by blockade of type I interferon signaling</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1126/science.1235214</pub-id><?supplied-pmid 23580529?><pub-id pub-id-type="pmid">23580529</pub-id></element-citation></ref><ref id="B62-ijms-18-02725"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name></person-group><article-title>IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors</article-title><source>Nat. Rev. Immunol.</source><year>2006</year><volume>6</volume><fpage>644</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/nri1900</pub-id><?supplied-pmid 16932750?><pub-id pub-id-type="pmid">16932750</pub-id></element-citation></ref><ref id="B63-ijms-18-02725"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Takaoka</surname><given-names>A.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name></person-group><article-title>Type I inteferon gene induction by the interferon regulatory factor family of transcription factors</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>349</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.009</pub-id><?supplied-pmid 16979567?><pub-id pub-id-type="pmid">16979567</pub-id></element-citation></ref><ref id="B64-ijms-18-02725"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Bohsali</surname><given-names>A.</given-names></name><name><surname>Ahlbrand</surname><given-names>S.E.</given-names></name><name><surname>Srinivasan</surname><given-names>L.</given-names></name><name><surname>Rathinam</surname><given-names>V.A.</given-names></name><name><surname>Vogel</surname><given-names>S.N.</given-names></name><name><surname>Fitzgerald</surname><given-names>K.A.</given-names></name><name><surname>Sutterwala</surname><given-names>F.S.</given-names></name><name><surname>Briken</surname><given-names>V.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> but not non-virulent mycobacteria inhibit IFN-&#x003b2; and AIM2-inflammasome dependent IL-1&#x003b2; production via their ESX-1 secretion system</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>3514</fpage><lpage>3518</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301331</pub-id><?supplied-pmid 23997220?><pub-id pub-id-type="pmid">23997220</pub-id></element-citation></ref><ref id="B65-ijms-18-02725"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A.K.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Fortune</surname><given-names>S.M.</given-names></name><name><surname>Coulombe</surname><given-names>F.</given-names></name></person-group><article-title>NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to <italic>Mycobacterium tuberculosis</italic></article-title><source>PLoS Pathog.</source><year>2009</year><volume>5</volume><elocation-id>e1000500</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id><?supplied-pmid 19578435?><pub-id pub-id-type="pmid">19578435</pub-id></element-citation></ref><ref id="B66-ijms-18-02725"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzanillo</surname><given-names>P.S.</given-names></name><name><surname>Shiloh</surname><given-names>M.U.</given-names></name><name><surname>Portnoy</surname><given-names>D.A.</given-names></name><name><surname>Cox</surname><given-names>J.S.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> activates the DNA-dependent cytosolic surveillance pathway within macrophages</article-title><source>Cell Host Microbe</source><year>2012</year><volume>11</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.03.007</pub-id><?supplied-pmid 22607800?><pub-id pub-id-type="pmid">22607800</pub-id></element-citation></ref><ref id="B67-ijms-18-02725"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassermann</surname><given-names>R.</given-names></name><name><surname>Gulen</surname><given-names>M.F.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Perin</surname><given-names>S.G.</given-names></name><name><surname>Lou</surname><given-names>Y.</given-names></name><name><surname>Rybniker</surname><given-names>J.</given-names></name><name><surname>Schmid-Burgk</surname><given-names>J.L.</given-names></name><name><surname>Schmidt</surname><given-names>T.</given-names></name><name><surname>Hornung</surname><given-names>V.</given-names></name><name><surname>Cole</surname><given-names>S.T.</given-names></name><etal/></person-group><article-title><italic>Mycobacterium tuberculosis</italic> differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1</article-title><source>Cell Host Microbe</source><year>2015</year><volume>17</volume><fpage>799</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.05.003</pub-id><?supplied-pmid 26048138?><pub-id pub-id-type="pmid">26048138</pub-id></element-citation></ref><ref id="B68-ijms-18-02725"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>L.J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>F.H.</given-names></name><name><surname>Shi</surname><given-names>H.P.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Zhijian</surname><given-names>J.C.</given-names></name></person-group><article-title>Cyclic-GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA</article-title><source>Science</source><year>2013</year><volume>15</volume><fpage>339</fpage><pub-id pub-id-type="doi">10.1126/science.1229963</pub-id><?supplied-pmid 23258412?><pub-id pub-id-type="pmid">23258412</pub-id></element-citation></ref><ref id="B69-ijms-18-02725"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>R.O.</given-names></name><name><surname>Bell</surname><given-names>S.L.</given-names></name><name><surname>MacDuff</surname><given-names>D.</given-names></name><name><surname>AKimmey</surname><given-names>J.M.</given-names></name><name><surname>Diner</surname><given-names>E.J.</given-names></name><name><surname>Olivas</surname><given-names>J.</given-names></name><name><surname>Vance</surname><given-names>R.E.</given-names></name><name><surname>Stallings</surname><given-names>C.L.</given-names></name><name><surname>Virgin</surname><given-names>H.W.</given-names></name><name><surname>Cox</surname><given-names>J.S.</given-names></name></person-group><article-title>The cytosolic sensor cGAS detects <italic>Mycobacterium tuberculosis</italic> DNA to induce type I interferons and activate autophagy</article-title><source>Cell Host Microbe</source><year>2015</year><volume>17</volume><fpage>811</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.05.004</pub-id><?supplied-pmid 26048136?><pub-id pub-id-type="pmid">26048136</pub-id></element-citation></ref><ref id="B70-ijms-18-02725"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F.W.</given-names></name><name><surname>Ewbank</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group><article-title>TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>1732</fpage><lpage>1743</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300146</pub-id><?supplied-pmid 23842752?><pub-id pub-id-type="pmid">23842752</pub-id></element-citation></ref><ref id="B71-ijms-18-02725"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiens</surname><given-names>K.E.</given-names></name><name><surname>Ernst</surname><given-names>J.D.</given-names></name></person-group><article-title>The Mechanism for Type I Interferon Induction by <italic>Mycobacterium tuberculosis</italic> is Bacterial Strain-Dependent</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><elocation-id>e1005809</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005809</pub-id><?supplied-pmid 27500737?><pub-id pub-id-type="pmid">27500737</pub-id></element-citation></ref><ref id="B72-ijms-18-02725"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Yue</surname><given-names>R.C.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>Y.Y.</given-names></name><name><surname>Yang</surname><given-names>L.F.</given-names></name><name><surname>Zhao</surname><given-names>D.M.</given-names></name><name><surname>Zhou</surname><given-names>X.M.</given-names></name></person-group><article-title>AIM2 inhibits autophagy and IFN-&#x003b2; production during M</article-title><source>bovis infection. Oncotarget</source><year>2016</year><volume>30</volume><fpage>46972</fpage><lpage>46987</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.10503</pub-id><?supplied-pmid 27409673?><pub-id pub-id-type="pmid">27409673</pub-id></element-citation></ref><ref id="B73-ijms-18-02725"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>C.A.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Franco</surname><given-names>L.H.</given-names></name><name><surname>Li</surname><given-names>X.D.</given-names></name><name><surname>Nair</surname><given-names>V.R.</given-names></name><name><surname>Scharn</surname><given-names>C.R.</given-names></name><name><surname>Stamm</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.J.</given-names></name><name><surname>Shiloh</surname><given-names>M.U.</given-names></name></person-group><article-title>Cyclic GMP-AMP Synthase (cGAS) is an Innate Immune DNA Sensor for <italic>Mycobacterium tuberculosis</italic></article-title><source>Cell Host Microbe</source><year>2015</year><volume>6</volume><fpage>820</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.05.005</pub-id><?supplied-pmid 26048137?><pub-id pub-id-type="pmid">26048137</pub-id></element-citation></ref><ref id="B74-ijms-18-02725"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohoff</surname><given-names>M.</given-names></name><name><surname>Mak</surname><given-names>T.W.</given-names></name></person-group><article-title>Roles of interferon-regulatory factors in T-helper-cell differentiation</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>5</volume><fpage>125</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nri1552</pub-id><?supplied-pmid 15688040?><pub-id pub-id-type="pmid">15688040</pub-id></element-citation></ref><ref id="B75-ijms-18-02725"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamane</surname><given-names>Y.</given-names></name><name><surname>Heylbroeck</surname><given-names>C.</given-names></name><name><surname>Genin</surname><given-names>P.</given-names></name><name><surname>Algarte</surname><given-names>M.</given-names></name><name><surname>Servant</surname><given-names>M.J.</given-names></name><name><surname>LePage</surname><given-names>C.</given-names></name><name><surname>DeLuca</surname><given-names>C.</given-names></name><name><surname>Kwon</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>R.</given-names></name><name><surname>Hiscott</surname><given-names>J.</given-names></name></person-group><article-title>Interferon regulatory factors: The next generation</article-title><source>Gene</source><year>1999</year><volume>237</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(99)00262-0</pub-id><pub-id pub-id-type="pmid">10524230</pub-id></element-citation></ref><ref id="B76-ijms-18-02725"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T.</given-names></name><name><surname>Takaoka</surname><given-names>A.</given-names></name></person-group><article-title>A weak signal for strong responses: Interferon-&#x003b1;/&#x003b2; revisited</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2001</year><volume>2</volume><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/35073080</pub-id><?supplied-pmid 11331912?><pub-id pub-id-type="pmid">11331912</pub-id></element-citation></ref><ref id="B77-ijms-18-02725"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>R.</given-names></name><name><surname>Heylbroeck</surname><given-names>C.</given-names></name><name><surname>Pitha</surname><given-names>P.M.</given-names></name><name><surname>Hiscott</surname><given-names>J.</given-names></name></person-group><article-title>Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and roteasomemediated degradation</article-title><source>Mol. Cell Biol.</source><year>1998</year><volume>18</volume><fpage>2986</fpage><lpage>2996</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.5.2986</pub-id><?supplied-pmid 9566918?><pub-id pub-id-type="pmid">9566918</pub-id></element-citation></ref><ref id="B78-ijms-18-02725"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Hata</surname><given-names>N.</given-names></name><name><surname>Oda</surname><given-names>E.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name></person-group><article-title>Involvement of the IRF family transcription factor IRF-3 in virusinduced activation of the <italic>IFN-&#x003b2;</italic> gene</article-title><source>FEBS Lett.</source><year>1998</year><volume>425</volume><fpage>112</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(98)00210-5</pub-id><pub-id pub-id-type="pmid">9541017</pub-id></element-citation></ref><ref id="B79-ijms-18-02725"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Hata</surname><given-names>N.</given-names></name><name><surname>Asagiri</surname><given-names>M.</given-names></name><name><surname>Nakaya</surname><given-names>T.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name></person-group><article-title>Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7</article-title><source>FEBS Lett.</source><year>1998</year><volume>441</volume><fpage>106</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01514-2</pub-id><pub-id pub-id-type="pmid">9877175</pub-id></element-citation></ref><ref id="B80-ijms-18-02725"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname><given-names>I.</given-names></name><name><surname>Durbin</surname><given-names>J.E.</given-names></name><name><surname>Levy</surname><given-names>D.E.</given-names></name></person-group><article-title>Differential viral induction of distinct interferon-&#x003b1; genes by positive feedback through interferon regulatory factor-7</article-title><source>EMBO J.</source><year>1998</year><volume>17</volume><fpage>6660</fpage><lpage>6669</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.22.6660</pub-id><?supplied-pmid 9822609?><pub-id pub-id-type="pmid">9822609</pub-id></element-citation></ref><ref id="B81-ijms-18-02725"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hata</surname><given-names>N.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Takaoka</surname><given-names>A.</given-names></name><name><surname>Asagiri</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name></person-group><article-title>Constitutive IFN-&#x003b1;/&#x003b2; signal for efficient <italic>IFN-&#x003b1;/&#x003b2;</italic> gene induction by virus</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2001</year><volume>285</volume><fpage>518</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5159</pub-id><?supplied-pmid 11444873?><pub-id pub-id-type="pmid">11444873</pub-id></element-citation></ref><ref id="B82-ijms-18-02725"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Yanai</surname><given-names>H.</given-names></name><name><surname>Negishi</surname><given-names>H.</given-names></name><name><surname>Asagiri</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Mizutani</surname><given-names>T.</given-names></name><name><surname>Shimada</surname><given-names>N.</given-names></name><name><surname>Ohba</surname><given-names>Y.</given-names></name><name><surname>Takaoka</surname><given-names>A.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><etal/></person-group><article-title>IRF-7 is the master regulator of type-I interferon-dependent immune responses</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1038/nature03464</pub-id><?supplied-pmid 15800576?><pub-id pub-id-type="pmid">15800576</pub-id></element-citation></ref><ref id="B83-ijms-18-02725"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Suemori</surname><given-names>H.</given-names></name><name><surname>Hata</surname><given-names>N.</given-names></name><name><surname>Asagiri</surname><given-names>M.</given-names></name><name><surname>Ogasawara</surname><given-names>K.</given-names></name><name><surname>Nakao</surname><given-names>K.</given-names></name><name><surname>Nakaya</surname><given-names>T.</given-names></name><name><surname>Katsuki</surname><given-names>M.</given-names></name><name><surname>Noguchi</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for <italic>IFN-&#x003b1;/&#x003b2;</italic> gene induction</article-title><source>Immunity</source><year>2000</year><volume>13</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)00053-4</pub-id><pub-id pub-id-type="pmid">11070172</pub-id></element-citation></ref><ref id="B84-ijms-18-02725"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlandsson</surname><given-names>L.</given-names></name><name><surname>Blumenthal</surname><given-names>R.</given-names></name><name><surname>Eloranta</surname><given-names>M.L.</given-names></name></person-group><article-title>Interferon-&#x003b2; is required for interferon-a production in mouse fibroblasts</article-title><source>Curr. Biol.</source><year>1998</year><volume>8</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(98)70086-7</pub-id><pub-id pub-id-type="pmid">9501984</pub-id></element-citation></ref><ref id="B85-ijms-18-02725"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>S.</given-names></name><name><surname>Reutterer</surname><given-names>B.</given-names></name><name><surname>Schaljo</surname><given-names>B.</given-names></name><name><surname>Schellack</surname><given-names>C.</given-names></name><name><surname>Brunner</surname><given-names>S.</given-names></name><name><surname>Materna</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><name><surname>Murray</surname><given-names>P.J.</given-names></name></person-group><article-title>IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism</article-title><source>J. Immunol.</source><year>2004</year><volume>173</volume><fpage>7416</fpage><lpage>7425</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.12.7416</pub-id><?supplied-pmid 15585867?><pub-id pub-id-type="pmid">15585867</pub-id></element-citation></ref><ref id="B86-ijms-18-02725"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>K.J.</given-names></name><name><surname>Coban</surname><given-names>C.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Torii</surname><given-names>Y.</given-names></name><name><surname>Takeshita</surname><given-names>F.</given-names></name><name><surname>Ludwig</surname><given-names>H.</given-names></name><name><surname>Sutter</surname><given-names>G.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Hemmi</surname><given-names>H.</given-names></name></person-group><article-title>A Toll-like receptor-independent antiviral response induced by doublestranded B-form DNA</article-title><source>Nat. Immunol.</source><year>2006</year><volume>7</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/ni1282</pub-id><?supplied-pmid 16286919?><pub-id pub-id-type="pmid">16286919</pub-id></element-citation></ref><ref id="B87-ijms-18-02725"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>D.B.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Recognition of cytosolic DNA activates an IRF3-dependent innate immune response</article-title><source>Immunity</source><year>2006</year><volume>24</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.12.003</pub-id><?supplied-pmid 16413926?><pub-id pub-id-type="pmid">16413926</pub-id></element-citation></ref><ref id="B88-ijms-18-02725"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>J.</given-names></name><name><surname>Muhlradt</surname><given-names>P.F.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Hoshino</surname><given-names>K.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS inducible genes</article-title><source>J. Immunol.</source><year>2001</year><volume>167</volume><fpage>5887</fpage><lpage>5894</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.10.5887</pub-id><?supplied-pmid 11698465?><pub-id pub-id-type="pmid">11698465</pub-id></element-citation></ref><ref id="B89-ijms-18-02725"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>S.</given-names></name><name><surname>Vaidya</surname><given-names>S.</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>R.</given-names></name><name><surname>Dadgostar</surname><given-names>H.</given-names></name><name><surname>Dempsey</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Rao</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>R.</given-names></name><name><surname>Haberland</surname><given-names>M.</given-names></name><name><surname>Modlin</surname><given-names>R.</given-names></name><etal/></person-group><article-title>IRF3 mediates a TLR3/TLR4-specific antiviral gene program</article-title><source>Immunity</source><year>2002</year><volume>17</volume><fpage>251</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00390-4</pub-id><pub-id pub-id-type="pmid">12354379</pub-id></element-citation></ref><ref id="B90-ijms-18-02725"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Adachi</surname><given-names>O.</given-names></name><name><surname>Ogawa</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Unresponsiveness of MyD88-deficient mice to endotoxin</article-title><source>Immunity</source><year>1999</year><volume>11</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80086-2</pub-id><pub-id pub-id-type="pmid">10435584</pub-id></element-citation></ref><ref id="B91-ijms-18-02725"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulou</surname><given-names>L.</given-names></name><name><surname>Holt</surname><given-names>A.C.</given-names></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name><name><surname>Flavell</surname><given-names>R.A.</given-names></name></person-group><article-title>Recognition of double-stranded RNA and activation of NF-&#x003ba;B by Toll-like receptor 3</article-title><source>Nature</source><year>2001</year><volume>413</volume><fpage>732</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/35099560</pub-id><?supplied-pmid 11607032?><pub-id pub-id-type="pmid">11607032</pub-id></element-citation></ref><ref id="B92-ijms-18-02725"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Au</surname><given-names>W.C.</given-names></name><name><surname>Moore</surname><given-names>P.A.</given-names></name><name><surname>Lowther</surname><given-names>W.</given-names></name><name><surname>Juang</surname><given-names>Y.T.</given-names></name><name><surname>Pitha</surname><given-names>P.M.</given-names></name></person-group><article-title>Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes</article-title><source>Proc. Nat. Acad. Sci. USA</source><year>1995</year><volume>25</volume><fpage>11657</fpage><lpage>11661</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.25.11657</pub-id></element-citation></ref><ref id="B93-ijms-18-02725"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadler</surname><given-names>M.</given-names></name><name><surname>Chelbi-Alix</surname><given-names>M.K.</given-names></name><name><surname>Koken</surname><given-names>M.H.</given-names></name><name><surname>Venturini</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Saib</surname><given-names>A.</given-names></name><name><surname>Quignon</surname><given-names>F.</given-names></name><name><surname>Pelicano</surname><given-names>L.</given-names></name><name><surname>Guillemin</surname><given-names>M.C.</given-names></name><name><surname>Schindler</surname><given-names>C.</given-names></name></person-group><article-title>Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element</article-title><source>Oncogene</source><year>1995</year><volume>12</volume><fpage>2565</fpage><lpage>2573</lpage></element-citation></ref><ref id="B94-ijms-18-02725"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaya</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Hata</surname><given-names>N.</given-names></name><name><surname>Asagiri</surname><given-names>M.</given-names></name><name><surname>Suemori</surname><given-names>H.</given-names></name><name><surname>Noguchi</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name></person-group><article-title>Gene induction pathways mediated by distinct IRFs during viral infection</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2001</year><volume>283</volume><fpage>1150</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.4913</pub-id><?supplied-pmid 11355893?><pub-id pub-id-type="pmid">11355893</pub-id></element-citation></ref><ref id="B95-ijms-18-02725"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.E.</given-names></name><name><surname>Hayward</surname><given-names>G.S.</given-names></name></person-group><article-title>The KSHV immediate early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation</article-title><source>Immunity</source><year>2005</year><volume>22</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.11.011</pub-id><?supplied-pmid 15664159?><pub-id pub-id-type="pmid">15664159</pub-id></element-citation></ref><ref id="B96-ijms-18-02725"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oeckinghaus</surname><given-names>A.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>The NF-&#x003ba;B Family of Transcription Factors and Its Regulation</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2009</year><volume>1</volume><fpage>a000034</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a000034</pub-id><?supplied-pmid 20066092?><pub-id pub-id-type="pmid">20066092</pub-id></element-citation></ref><ref id="B97-ijms-18-02725"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>A.S.</given-names></name></person-group><article-title>The NF-&#x003ba;B and I&#x003ba;B proteins: New discoveries and insights</article-title><source>Annu. Rev. Immunol.</source><year>1996</year><volume>14</volume><fpage>649</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.14.1.649</pub-id><?supplied-pmid 8717528?><pub-id pub-id-type="pmid">8717528</pub-id></element-citation></ref><ref id="B98-ijms-18-02725"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Uematsu</surname><given-names>S.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name></person-group><article-title>Pathogen recognition and innate immunity</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>783</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.02.015</pub-id><?supplied-pmid 16497588?><pub-id pub-id-type="pmid">16497588</pub-id></element-citation></ref><ref id="B99-ijms-18-02725"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>Funami</surname><given-names>K.</given-names></name><name><surname>Tanabe</surname><given-names>M.</given-names></name><name><surname>Oshiumi</surname><given-names>H.</given-names></name><name><surname>Shingai</surname><given-names>M.</given-names></name><name><surname>Seto</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Seya</surname><given-names>T.</given-names></name></person-group><article-title>Subcellular localization of Toll-like receptor 3 in human dendritic cells</article-title><source>J. Immunol.</source><year>2003</year><volume>171</volume><fpage>3154</fpage><lpage>3162</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.6.3154</pub-id><?supplied-pmid 12960343?><pub-id pub-id-type="pmid">12960343</pub-id></element-citation></ref><ref id="B100-ijms-18-02725"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>K.A.</given-names></name><name><surname>McWhirter</surname><given-names>S.M.</given-names></name><name><surname>Faia</surname><given-names>K.L.</given-names></name><name><surname>Rowe</surname><given-names>D.C.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name><name><surname>Golenbock</surname><given-names>D.T.</given-names></name><name><surname>Coyle</surname><given-names>A.J.</given-names></name><name><surname>Liao</surname><given-names>S.M.</given-names></name><name><surname>Maniatis</surname><given-names>T.</given-names></name></person-group><article-title>IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway</article-title><source>Nat. Immunol.</source><year>2003</year><volume>4</volume><fpage>491</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/ni921</pub-id><?supplied-pmid 12692549?><pub-id pub-id-type="pmid">12692549</pub-id></element-citation></ref><ref id="B101-ijms-18-02725"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>A.K.</given-names></name><name><surname>Chow</surname><given-names>E.K.</given-names></name><name><surname>Goodnough</surname><given-names>J.B.</given-names></name><name><surname>Yeh</surname><given-names>W.C.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name></person-group><article-title>Differential requirement for TANK binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection</article-title><source>J. Exp. Med.</source><year>2004</year><volume>199</volume><fpage>1651</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1084/jem.20040528</pub-id><?supplied-pmid 15210743?><pub-id pub-id-type="pmid">15210743</pub-id></element-citation></ref><ref id="B102-ijms-18-02725"><label>102.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brasier</surname><given-names>A.R.</given-names></name></person-group><article-title>The NF-&#x003ba;&#x003b2; signaling network: Insights from systems approaches</article-title><source>Cellular Signaling and Innate Immune Responses to RNA Virus Infections</source><person-group person-group-type="editor"><name><surname>Brasier</surname><given-names>A.R.</given-names></name><name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name><name><surname>Lemon</surname><given-names>S.M.</given-names></name></person-group><publisher-name>ASM Press</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2008</year><fpage>119</fpage><lpage>135</lpage></element-citation></ref><ref id="B103-ijms-18-02725"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Kimbrel</surname><given-names>E.A.</given-names></name><name><surname>Kenan</surname><given-names>D.J.</given-names></name><name><surname>McDonnell</surname><given-names>D.P.</given-names></name></person-group><article-title>Direct interactions between corepressors and coactivators permit the integration of nuclear receptor mediated repression and activation</article-title><source>Mol. Endocrinol.</source><year>2002</year><volume>16</volume><fpage>1482</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1210/mend.16.7.0860</pub-id><?supplied-pmid 12089344?><pub-id pub-id-type="pmid">12089344</pub-id></element-citation></ref><ref id="B104-ijms-18-02725"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>T.</given-names></name><name><surname>Hoffmann</surname><given-names>A.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group><article-title>One nucleotide in a &#x003ba;B site can determine cofactor specificity for NF-&#x003ba;B dimers</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.08.007</pub-id><?supplied-pmid 15315758?><pub-id pub-id-type="pmid">15315758</pub-id></element-citation></ref><ref id="B105-ijms-18-02725"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perissi</surname><given-names>V.</given-names></name><name><surname>Aggarwal</surname><given-names>A.</given-names></name><name><surname>Glass</surname><given-names>C.K.</given-names></name><name><surname>Rose</surname><given-names>D.W.</given-names></name><name><surname>Rosenfeld</surname><given-names>M.G.</given-names></name></person-group><article-title>A core repressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>511</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(04)00133-3</pub-id><pub-id pub-id-type="pmid">14980219</pub-id></element-citation></ref><ref id="B106-ijms-18-02725"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S.</given-names></name><name><surname>Lozach</surname><given-names>J.</given-names></name><name><surname>Pascua</surname><given-names>I.G.</given-names></name><name><surname>Tangirala</surname><given-names>R.K.</given-names></name><name><surname>Westin</surname><given-names>S.</given-names></name></person-group><article-title>Molecular determinants of crosstalk between nuclear receptors and toll-like receptors</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>707</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.06.029</pub-id><?supplied-pmid 16143103?><pub-id pub-id-type="pmid">16143103</pub-id></element-citation></ref><ref id="B107-ijms-18-02725"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theofilopoulos</surname><given-names>A.N.</given-names></name><name><surname>Baccala</surname><given-names>R.</given-names></name><name><surname>Beutler</surname><given-names>B.</given-names></name><name><surname>Kono</surname><given-names>D.H.</given-names></name></person-group><article-title>Type I interferons (&#x003b1;/&#x003b2;) in immunity and autoimmunity</article-title><source>Annu. Rev. Immunol.</source><year>2005</year><volume>23</volume><fpage>307</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115843</pub-id><?supplied-pmid 15771573?><pub-id pub-id-type="pmid">15771573</pub-id></element-citation></ref><ref id="B108-ijms-18-02725"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>G.</given-names></name><name><surname>Midiri</surname><given-names>A.</given-names></name><name><surname>Biondo</surname><given-names>C.</given-names></name><name><surname>Beninati</surname><given-names>C.</given-names></name><name><surname>Zummo</surname><given-names>S.</given-names></name><name><surname>Galbo</surname><given-names>R.</given-names></name><name><surname>Tomasello</surname><given-names>F.</given-names></name><name><surname>Gambuzza</surname><given-names>M.</given-names></name><name><surname>Macr&#x000ec;</surname><given-names>G.</given-names></name><name><surname>Ruggeri</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>3126</fpage><lpage>3133</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3126</pub-id><?supplied-pmid 17312160?><pub-id pub-id-type="pmid">17312160</pub-id></element-citation></ref><ref id="B109-ijms-18-02725"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Weerd</surname><given-names>N.A.</given-names></name><name><surname>Vivian</surname><given-names>J.P.</given-names></name><name><surname>Nguyen</surname><given-names>T.K.</given-names></name><name><surname>Mangan</surname><given-names>N.E.</given-names></name><name><surname>Gould</surname><given-names>J.A.</given-names></name><name><surname>Braniff</surname><given-names>S.J.</given-names></name><name><surname>Zaker-Tabrizi</surname><given-names>L.</given-names></name><name><surname>Fung</surname><given-names>K.Y.</given-names></name><name><surname>Forster</surname><given-names>S.C.</given-names></name><name><surname>Beddoe</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Structural basis of a unique interferon-&#x003b2; signaling axis mediated via the receptor IFNAR1</article-title><source>Nat. Immunol.</source><year>2013</year><volume>9</volume><fpage>901</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1038/ni.2667</pub-id><?supplied-pmid 23872679?><pub-id pub-id-type="pmid">23872679</pub-id></element-citation></ref><ref id="B110-ijms-18-02725"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname><given-names>D.N.</given-names></name><name><surname>Risac</surname><given-names>B.C.</given-names></name><name><surname>John</surname><given-names>S.P.</given-names></name><name><surname>Huang</surname><given-names>Y.W.</given-names></name><name><surname>Chin</surname><given-names>C.R.</given-names></name><name><surname>Xie</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Jilg</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chevaliez</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A genetic screen identifies interferon-&#x003b1; effector genes required to suppress hepatitis C virus replication</article-title><source>Gastroenterology</source><year>2013</year><volume>144</volume><fpage>1438</fpage><lpage>1449</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.02.026</pub-id><?supplied-pmid 23462180?><pub-id pub-id-type="pmid">23462180</pub-id></element-citation></ref><ref id="B111-ijms-18-02725"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname><given-names>S.</given-names></name></person-group><article-title>Interferon signatures in immune disorders and disease</article-title><source>Immunol. Cell Biol.</source><year>2012</year><volume>90</volume><fpage>520</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/icb.2012.12</pub-id><?supplied-pmid 22491066?><pub-id pub-id-type="pmid">22491066</pub-id></element-citation></ref><ref id="B112-ijms-18-02725"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Chung</surname><given-names>R.T.</given-names></name></person-group><article-title>A functional genomic screen reveals novel host genes that mediate interferon-&#x003b1;&#x02019;s effects against hepatitis C virus</article-title><source>J. Hepatol.</source><year>2012</year><volume>56</volume><fpage>326</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2011.07.026</pub-id><?supplied-pmid 21888876?><pub-id pub-id-type="pmid">21888876</pub-id></element-citation></ref><ref id="B113-ijms-18-02725"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Q.L.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>X.Y.</given-names></name><name><surname>Liu</surname><given-names>X.M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Z.D.</given-names></name></person-group><article-title>Identification of latent tuberculosis infectionrelated microRNAs in human U937 macrophages expressing <italic>Mycobacterium tuberculosis</italic> Hsp16.3</article-title><source>BMC Microbiol.</source><year>2014</year><volume>14</volume><elocation-id>37</elocation-id><pub-id pub-id-type="pmid">24521422</pub-id></element-citation></ref><ref id="B114-ijms-18-02725"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoggins</surname><given-names>J.W.</given-names></name><name><surname>MacDuff</surname><given-names>D.A.</given-names></name><name><surname>Imanaka</surname><given-names>N.</given-names></name><name><surname>Gainey</surname><given-names>M.D.</given-names></name><name><surname>Shrestha</surname><given-names>B.</given-names></name><name><surname>Eitson</surname><given-names>J.L.</given-names></name><name><surname>Mar</surname><given-names>K.B.</given-names></name><name><surname>Richardson</surname><given-names>R.B.</given-names></name><name><surname>Ratushny</surname><given-names>A.V.</given-names></name><name><surname>Litvak</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity</article-title><source>Nature</source><year>2014</year><volume>7485</volume><fpage>691</fpage><lpage>695</lpage></element-citation></ref><ref id="B115-ijms-18-02725"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rongvaux</surname><given-names>A.</given-names></name><name><surname>Jackson</surname><given-names>R.</given-names></name><name><surname>Harman</surname><given-names>C.C.D.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>West</surname><given-names>A.P.</given-names></name><name><surname>de Zoete</surname><given-names>M.R.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yordy</surname><given-names>B.</given-names></name><name><surname>Lakhani</surname><given-names>S.A.</given-names></name><name><surname>Kuan</surname><given-names>C.Y.</given-names></name><etal/></person-group><article-title>Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1563</fpage><lpage>1577</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.037</pub-id><?supplied-pmid 25525875?><pub-id pub-id-type="pmid">25525875</pub-id></element-citation></ref><ref id="B116-ijms-18-02725"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogunovic</surname><given-names>D.</given-names></name><name><surname>Byun</surname><given-names>M.</given-names></name><name><surname>Durfee</surname><given-names>L.A.</given-names></name><name><surname>Abhyankar</surname><given-names>A.</given-names></name><name><surname>Sanal</surname><given-names>O.</given-names></name><name><surname>Mansouri</surname><given-names>D.</given-names></name><name><surname>Salem</surname><given-names>S.</given-names></name><name><surname>Radovanovic</surname><given-names>A.</given-names></name><name><surname>Grant</surname><given-names>V.</given-names></name><name><surname>Adimi</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Mycobacterial disease and impaired IFN-&#x003b3; immunity in humans with inherited ISG15 deficiency</article-title><source>Science</source><year>2012</year><volume>337</volume><fpage>1684</fpage><lpage>1688</lpage><pub-id pub-id-type="doi">10.1126/science.1224026</pub-id><?supplied-pmid 22859821?><pub-id pub-id-type="pmid">22859821</pub-id></element-citation></ref><ref id="B117-ijms-18-02725"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M.</given-names></name></person-group><article-title>Recombinant murine &#x003b2; interferon enhances resistance of mice to systemic <italic>Mycobacterium avium</italic> infection</article-title><source>Infect. Immunol.</source><year>1991</year><volume>59</volume><fpage>1857</fpage><lpage>1859</lpage><pub-id pub-id-type="pmid">2019446</pub-id></element-citation></ref><ref id="B118-ijms-18-02725"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>C.I.</given-names></name><name><surname>Graham</surname><given-names>C.M.</given-names></name><name><surname>Berry</surname><given-names>M.P.</given-names></name><name><surname>Wilkinson</surname><given-names>K.A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Rozakeas</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Rossello-Urgell</surname><given-names>J.</given-names></name><name><surname>Chaussabel</surname><given-names>D.</given-names></name><name><surname>Banchereau</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e46191</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046191</pub-id><?supplied-pmid 23056259?><pub-id pub-id-type="pmid">23056259</pub-id></element-citation></ref><ref id="B119-ijms-18-02725"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchonnet</surname><given-names>F.</given-names></name><name><surname>Boechat</surname><given-names>N.</given-names></name><name><surname>Bonay</surname><given-names>M.</given-names></name><name><surname>Hance</surname><given-names>A.J.</given-names></name></person-group><article-title>&#x003b1;/&#x003b2; interferon impairs the ability of human macrophages to control growth of <italic>Mycobacterium bovis</italic> BCG</article-title><source>Infect. Immunol.</source><year>2002</year><volume>70</volume><fpage>3020</fpage><lpage>3025</lpage><pub-id pub-id-type="doi">10.1128/IAI.70.6.3020-3025.2002</pub-id><pub-id pub-id-type="pmid">12010993</pub-id></element-citation></ref><ref id="B120-ijms-18-02725"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>R.M.</given-names></name><name><surname>Saha</surname><given-names>S.K.</given-names></name><name><surname>Vaidya</surname><given-names>S.A.</given-names></name><name><surname>Bruhn</surname><given-names>K.W.</given-names></name><name><surname>Miranda</surname><given-names>G.A.</given-names></name><name><surname>Zarnegar</surname><given-names>B.</given-names></name><name><surname>Perry</surname><given-names>A.K.</given-names></name><name><surname>Nguyen</surname><given-names>B.O.</given-names></name><name><surname>Lane</surname><given-names>T.F.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Type I interferon production enhances susceptibility to <italic>Listeria</italic> monocytogenes infection</article-title><source>J. Exp. Med.</source><year>2004</year><volume>200</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1084/jem.20040712</pub-id><?supplied-pmid 15302901?><pub-id pub-id-type="pmid">15302901</pub-id></element-citation></ref><ref id="B121-ijms-18-02725"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Bergtold</surname><given-names>A.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Musser</surname><given-names>J.M.</given-names></name><name><surname>Barry</surname><given-names>C.E.</given-names></name><name><surname>Freedman</surname><given-names>V.H.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group><article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-&#x003b1;/&#x003b2;</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>5752</fpage><lpage>5757</lpage><pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><?supplied-pmid 11320211?><pub-id pub-id-type="pmid">11320211</pub-id></element-citation></ref><ref id="B122-ijms-18-02725"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>L.R.</given-names></name><name><surname>Gigliotti</surname><given-names>R.A.</given-names></name><name><surname>Goncalves</surname><given-names>R.</given-names></name><name><surname>Roffe</surname><given-names>E.</given-names></name><name><surname>Cheever</surname><given-names>A.W.</given-names></name><name><surname>Bafica</surname><given-names>A.</given-names></name></person-group><article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogenpermissive monocyte/macrophage population</article-title><source>J. Clin. Investig.</source><year>2010</year><volume>120</volume><fpage>1674</fpage><lpage>1682</lpage><pub-id pub-id-type="doi">10.1172/JCI40817</pub-id><?supplied-pmid 20389020?><pub-id pub-id-type="pmid">20389020</pub-id></element-citation></ref><ref id="B123-ijms-18-02725"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A.</given-names></name><name><surname>Yeremeev</surname><given-names>V.</given-names></name><name><surname>Kaufmann</surname><given-names>S.H.E.</given-names></name></person-group><article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title><source>Eur. J. Immunol.</source><year>2014</year><volume>44</volume><fpage>2380</fpage><lpage>2393</lpage><pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id><?supplied-pmid 24782112?><pub-id pub-id-type="pmid">24782112</pub-id></element-citation></ref><ref id="B124-ijms-18-02725"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Toledo-Pinto</surname><given-names>T.G.</given-names></name><name><surname>Ferreira</surname><given-names>A.B.</given-names></name><name><surname>Ribeiro-Alves</surname><given-names>M.</given-names></name><name><surname>Rodrigues</surname><given-names>L.S.</given-names></name><name><surname>Batista-Silva</surname><given-names>L.R.</given-names></name><name><surname>Silva</surname><given-names>B.J.</given-names></name><name><surname>Lemes</surname><given-names>R.M.</given-names></name><name><surname>Martinez</surname><given-names>A.N.</given-names></name><name><surname>Sandoval</surname><given-names>F.G.</given-names></name><name><surname>Alvarado-Arnez</surname><given-names>L.E.</given-names></name><etal/></person-group><article-title>STING-dependent 2&#x02032;-5&#x02032; oligoadenylate synthetase&#x02014;Like production is required for intracellular <italic>Mycobacterium leprae</italic> survival</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>214</volume><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw144</pub-id><?supplied-pmid 27190175?><pub-id pub-id-type="pmid">27190175</pub-id></element-citation></ref><ref id="B125-ijms-18-02725"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariotti</surname><given-names>S.</given-names></name><name><surname>Teloni</surname><given-names>R.</given-names></name><name><surname>Iona</surname><given-names>E.</given-names></name><name><surname>Fattorini</surname><given-names>L.</given-names></name><name><surname>Romagnoli</surname><given-names>G.</given-names></name><name><surname>Gagliardi</surname><given-names>M.C.</given-names></name><name><surname>Orefici</surname><given-names>G.</given-names></name><name><surname>Nisini</surname><given-names>R.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> Diverts &#x003b1; Interferon-Induced Monocyte Differentiation from Dendritic Cells into Immuno-privileged Macrophage-Like Host Cells</article-title><source>Infect. Immun.</source><year>2004</year><volume>72</volume><fpage>4385</fpage><lpage>4392</lpage><pub-id pub-id-type="doi">10.1128/IAI.72.8.4385-4392.2004</pub-id><?supplied-pmid 15271894?><pub-id pub-id-type="pmid">15271894</pub-id></element-citation></ref><ref id="B126-ijms-18-02725"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>E.B.</given-names></name><name><surname>Yamada</surname><given-names>D.H.</given-names></name><name><surname>Elsaesser</surname><given-names>H.</given-names></name><name><surname>Herskovitz</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name><name><surname>Aronow</surname><given-names>B.J.</given-names></name><name><surname>Karp</surname><given-names>C.L.</given-names></name><name><surname>Brooks</surname><given-names>D.G.</given-names></name></person-group><article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1126/science.1235208</pub-id><?supplied-pmid 23580528?><pub-id pub-id-type="pmid">23580528</pub-id></element-citation></ref><ref id="B127-ijms-18-02725"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulpa</surname><given-names>D.A.</given-names></name><name><surname>Lawani</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>A.</given-names></name><name><surname>Peretz</surname><given-names>Y.</given-names></name><name><surname>Ahlers</surname><given-names>J.</given-names></name><name><surname>Sekaly</surname><given-names>R.P.</given-names></name></person-group><article-title>PD-1 co-inhibitory signals: The link between pathogenesis and protection</article-title><source>Semin. Immunol.</source><year>2013</year><volume>25</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2013.02.002</pub-id><?supplied-pmid 23548749?><pub-id pub-id-type="pmid">23548749</pub-id></element-citation></ref><ref id="B128-ijms-18-02725"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S.</given-names></name><name><surname>Blumenthal</surname><given-names>A.</given-names></name><name><surname>Hickey</surname><given-names>C.M.</given-names></name><name><surname>Gandotra</surname><given-names>S.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ehrt</surname><given-names>S.</given-names></name></person-group><article-title>Expression of many immunologically important genes in <italic>Mycobacterium tuberculosis</italic>-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN- &#x003b1;&#x003b2; receptor and STAT1</article-title><source>J. Immunol.</source><year>2005</year><volume>75</volume><fpage>3318</fpage><lpage>3328</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.5.3318</pub-id></element-citation></ref><ref id="B129-ijms-18-02725"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F.W.</given-names></name><name><surname>Ewbank</surname><given-names>J.</given-names></name><name><surname>Howes</surname><given-names>A.</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L.</given-names></name><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Ghilardi</surname><given-names>N.</given-names></name><name><surname>Saraiva</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group><article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-&#x003b3; for production of IL-12 and bacterial killing in <italic>Mycobacterium tuberculosis</italic>-infected macrophages</article-title><source>J. Immunol.</source><year>2014</year><volume>193</volume><fpage>3600</fpage><lpage>3612</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1401088</pub-id><?supplied-pmid 25187652?><pub-id pub-id-type="pmid">25187652</pub-id></element-citation></ref><ref id="B130-ijms-18-02725"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S.</given-names></name><name><surname>Casarini</surname><given-names>M.</given-names></name><name><surname>Alemanno</surname><given-names>L.</given-names></name><name><surname>Galluccio</surname><given-names>G.</given-names></name><name><surname>Mattia</surname><given-names>P.</given-names></name><name><surname>Pedicelli</surname><given-names>G.</given-names></name><name><surname>Rebek</surname><given-names>L.</given-names></name><name><surname>Bisetti</surname><given-names>A.</given-names></name><name><surname>Ameglio</surname><given-names>F.</given-names></name></person-group><article-title>Effects of aerosolized interferon-&#x003b1; in patients with pulmonary tuberculosis</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>1998</year><volume>158</volume><fpage>1156</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.158.4.9803065</pub-id><?supplied-pmid 9769275?><pub-id pub-id-type="pmid">9769275</pub-id></element-citation></ref><ref id="B131-ijms-18-02725"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosu&#x000e8;</surname><given-names>S.</given-names></name><name><surname>Casarini</surname><given-names>M.</given-names></name><name><surname>Ameglio</surname><given-names>F.</given-names></name><name><surname>Zangrilli</surname><given-names>P.</given-names></name><name><surname>Palla</surname><given-names>M.</given-names></name><name><surname>Altieri</surname><given-names>A.M.</given-names></name><name><surname>Bisetti</surname><given-names>A.</given-names></name></person-group><article-title>Aerosolized interferon-&#x003b1; treatment in patients with multi-drug-resistant pulmonary tuberculosis</article-title><source>Eur. Cytokine Netw.</source><year>2000</year><volume>11</volume><fpage>99</fpage><lpage>103</lpage><?supplied-pmid 10705306?><pub-id pub-id-type="pmid">10705306</pub-id></element-citation></ref><ref id="B132-ijms-18-02725"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousens</surname><given-names>L.P.</given-names></name><name><surname>Peterson</surname><given-names>R.</given-names></name><name><surname>Hsu</surname><given-names>S.</given-names></name><name><surname>Dorner</surname><given-names>A.</given-names></name><name><surname>Altman</surname><given-names>J.D.</given-names></name><name><surname>Ahmed</surname><given-names>R.</given-names></name><name><surname>Biron</surname><given-names>C.A.</given-names></name></person-group><article-title>Two roads diverged: Interferon &#x003b1;/&#x003b2;- and interleukin 12-mediated pathways in promoting T cell interferon &#x003b1; responses during viral infection</article-title><source>J. Exp. Med.</source><year>1999</year><volume>189</volume><fpage>1315</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1084/jem.189.8.1315</pub-id><?supplied-pmid 10209048?><pub-id pub-id-type="pmid">10209048</pub-id></element-citation></ref><ref id="B133-ijms-18-02725"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname><given-names>P.</given-names></name><name><surname>Rubio</surname><given-names>M.</given-names></name><name><surname>Nakajima</surname><given-names>T.</given-names></name><name><surname>Delespesse</surname><given-names>G.</given-names></name><name><surname>Sarfati</surname><given-names>M.</given-names></name></person-group><article-title>IFN-&#x003b1; priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12 p70, CD80, and MHC class I expression</article-title><source>J. Immunol.</source><year>1998</year><volume>161</volume><fpage>2011</fpage><lpage>2018</lpage><?supplied-pmid 9712074?><pub-id pub-id-type="pmid">9712074</pub-id></element-citation></ref><ref id="B134-ijms-18-02725"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Collazo</surname><given-names>E.</given-names></name><name><surname>Hortelano</surname><given-names>S.</given-names></name><name><surname>Rojas</surname><given-names>A.</given-names></name><name><surname>Bosc&#x000e1;</surname><given-names>L.</given-names></name></person-group><article-title>Triggering of peritoneal macrophages with IFN-/ attenuates the expression of inducible nitric oxide synthase through a decrease in NF-B activation</article-title><source>J. Immunol.</source><year>1998</year><volume>160</volume><fpage>2889</fpage><lpage>2895</lpage><?supplied-pmid 9510192?><pub-id pub-id-type="pmid">9510192</pub-id></element-citation></ref><ref id="B135-ijms-18-02725"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippot</surname><given-names>V.</given-names></name><name><surname>Yassir</surname><given-names>F.</given-names></name><name><surname>Balme</surname><given-names>B.</given-names></name><name><surname>Perrot</surname><given-names>H.</given-names></name></person-group><article-title>Abc&#x000e8;s sous-cutan&#x000e9; &#x000e0; <italic>Mycobacterium avium-intracellulare</italic> apr&#x000e8;s injections d&#x02019;interf&#x000e9;ron &#x003b1; chez une malade trait&#x000e9;e pour lymphome</article-title><source>Ann. Dermatol. Venereol.</source><year>1996</year><volume>123</volume><fpage>103</fpage><lpage>105</lpage><?supplied-pmid 8761762?><pub-id pub-id-type="pmid">8761762</pub-id></element-citation></ref><ref id="B136-ijms-18-02725"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toren</surname><given-names>A.</given-names></name><name><surname>Ackerstein</surname><given-names>A.</given-names></name><name><surname>Gazit</surname><given-names>D.</given-names></name><name><surname>Or</surname><given-names>R.</given-names></name><name><surname>Raveh</surname><given-names>D.</given-names></name><name><surname>Kupolovicz</surname><given-names>U.</given-names></name><name><surname>Engelhard</surname><given-names>D.</given-names></name><name><surname>Naglar</surname><given-names>A.</given-names></name></person-group><article-title>Oral tuberculosis following autologous bone marrow transplantation for Hodgkin&#x02019;s disease with interleukin-2 and &#x003b1;-interferon immunotherapy</article-title><source>Bone Marrow Transplant.</source><year>1996</year><volume>18</volume><fpage>209</fpage><lpage>210</lpage><?supplied-pmid 8832017?><pub-id pub-id-type="pmid">8832017</pub-id></element-citation></ref><ref id="B137-ijms-18-02725"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhakar</surname><given-names>S.</given-names></name><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Hoshino</surname><given-names>Y.</given-names></name><name><surname>Weiden</surname><given-names>M.</given-names></name><name><surname>Canova</surname><given-names>A.</given-names></name><name><surname>Giacomini</surname><given-names>E.</given-names></name><name><surname>Coccia</surname><given-names>E.</given-names></name><name><surname>Pine</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of Response to &#x003b1; Interferon by <italic>Mycobacterium tuberculosis</italic></article-title><source>Infect. Immun.</source><year>2003</year><volume>71</volume><fpage>2487</fpage><lpage>2497</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.5.2487-2497.2003</pub-id><?supplied-pmid 12704120?><pub-id pub-id-type="pmid">12704120</pub-id></element-citation></ref><ref id="B138-ijms-18-02725"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Lao</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name></person-group><article-title>Tuberculosis antigen-induced expression of IFN-&#x003b1; in tuberculosis patients inhibits production of IL-1&#x003b2;</article-title><source>FASEB J.</source><year>2014</year><volume>28</volume><fpage>3238</fpage><lpage>3248</lpage><pub-id pub-id-type="doi">10.1096/fj.13-247056</pub-id><?supplied-pmid 24675363?><pub-id pub-id-type="pmid">24675363</pub-id></element-citation></ref><ref id="B139-ijms-18-02725"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briken</surname><given-names>V.</given-names></name><name><surname>Sarah</surname><given-names>E.A.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> and the host cell inflammasome: A complex relationship</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2013</year><volume>62</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3389/fcimb.2013.00062</pub-id><?supplied-pmid 24130966?><pub-id pub-id-type="pmid">24130966</pub-id></element-citation></ref><ref id="B140-ijms-18-02725"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>D.M.</given-names></name><name><surname>Jeon</surname><given-names>B.Y.</given-names></name><name><surname>Lee</surname><given-names>H.M.</given-names></name><name><surname>Jin</surname><given-names>H.S.</given-names></name><name><surname>Yuk</surname><given-names>J.M.</given-names></name><name><surname>Song</surname><given-names>C.H.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> eis regulates autophagy, inflammation, and cell death through redox-dependent signaling</article-title><source>PLoS Pathog.</source><year>2010</year><volume>6</volume><elocation-id>e1001230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1001230</pub-id><?supplied-pmid 21187903?><pub-id pub-id-type="pmid">21187903</pub-id></element-citation></ref><ref id="B141-ijms-18-02725"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zullo</surname><given-names>A.J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name></person-group><article-title>Mycobacterial induction of autophagy varies by species and occurs independently of mammalian target of rapamycin inhibition</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>12668</fpage><lpage>12678</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.320135</pub-id><?supplied-pmid 22275355?><pub-id pub-id-type="pmid">22275355</pub-id></element-citation></ref><ref id="B142-ijms-18-02725"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Brotcke</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>D.S.</given-names></name><name><surname>Thompson</surname><given-names>L.J.</given-names></name><name><surname>Monack</surname><given-names>D.M.</given-names></name></person-group><article-title>Type I interferon signaling is required for activation of the inflammasome during <italic>Francisella</italic> infection</article-title><source>J. Exp. Med.</source><year>2007</year><volume>204</volume><fpage>987</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1084/jem.20062665</pub-id><?supplied-pmid 17452523?><pub-id pub-id-type="pmid">17452523</pub-id></element-citation></ref><ref id="B143-ijms-18-02725"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J.W.</given-names></name><name><surname>Kayagaki</surname><given-names>N.</given-names></name><name><surname>Broz</surname><given-names>P.</given-names></name><name><surname>Henry</surname><given-names>T.</given-names></name><name><surname>Newton</surname><given-names>K.</given-names></name><name><surname>O&#x02019;rourke</surname><given-names>K.</given-names></name></person-group><article-title>Absent in melanoma 2 is required for innate immune recognition of <italic>Francisella tularensis</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>9771</fpage><lpage>9776</lpage><pub-id pub-id-type="doi">10.1073/pnas.1003738107</pub-id><?supplied-pmid 20457908?><pub-id pub-id-type="pmid">20457908</pub-id></element-citation></ref><ref id="B144-ijms-18-02725"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>H.</given-names></name><name><surname>Kawamura</surname><given-names>I.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Daim</surname><given-names>S.</given-names></name></person-group><article-title>Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with <italic>Listeria monocytogenes</italic></article-title><source>J. Immunol.</source><year>2010</year><volume>185</volume><fpage>1186</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1001058</pub-id><?supplied-pmid 20566831?><pub-id pub-id-type="pmid">20566831</pub-id></element-citation></ref><ref id="B145-ijms-18-02725"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes-Alnemri</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>J.W.</given-names></name><name><surname>Juliana</surname><given-names>C.</given-names></name><name><surname>Solorzano</surname><given-names>L.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><article-title>The AIM 2 inflammasome is critical for innate immunity to <italic>Francisella tularensis</italic></article-title><source>Nat. Immunol.</source><year>2010</year><volume>11</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/ni.1859</pub-id><?supplied-pmid 20351693?><pub-id pub-id-type="pmid">20351693</pub-id></element-citation></ref><ref id="B146-ijms-18-02725"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velmurugan</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Miller</surname><given-names>J.L.</given-names></name><name><surname>Azogue</surname><given-names>S.</given-names></name><name><surname>Gurses</surname><given-names>S.</given-names></name><name><surname>Hsu</surname><given-names>T.</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic> nuoG is a virulence gene that inhibits apoptosis of infected host cells</article-title><source>PLOS Pathog.</source><year>2007</year><volume>3</volume><elocation-id>e110</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030110</pub-id><?supplied-pmid 17658950?><pub-id pub-id-type="pmid">17658950</pub-id></element-citation></ref><ref id="B147-ijms-18-02725"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L.</given-names></name><name><surname>Wolf</surname><given-names>A.J.</given-names></name><name><surname>Ernst</surname><given-names>J.D.</given-names></name></person-group><article-title>Dynamic roles of type I and type II interferons in early infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J. Immunol.</source><year>2012</year><volume>12</volume><fpage>6205</fpage><lpage>6215</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1200255</pub-id><?supplied-pmid 22566567?><pub-id pub-id-type="pmid">22566567</pub-id></element-citation></ref><ref id="B148-ijms-18-02725"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>L.G.</given-names></name><name><surname>Chisari</surname><given-names>F.V.</given-names></name></person-group><article-title>Immunobiology and pathogenesis of viral hepatitis</article-title><source>Annu. Rev. Pathol.</source><year>2006</year><volume>1</volume><fpage>23</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1146/annurev.pathol.1.110304.100230</pub-id><?supplied-pmid 18039107?><pub-id pub-id-type="pmid">18039107</pub-id></element-citation></ref><ref id="B149-ijms-18-02725"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>A.I.</given-names></name><name><surname>Pezacki</surname><given-names>J.P.</given-names></name><name><surname>Wodicka</surname><given-names>L.</given-names></name><name><surname>Brideau</surname><given-names>A.D.</given-names></name><name><surname>Supekova</surname><given-names>L.</given-names></name><name><surname>Thimme</surname><given-names>R.</given-names></name><name><surname>Wieland</surname><given-names>S.</given-names></name><name><surname>Bukh</surname><given-names>J.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Schultz</surname><given-names>P.G.</given-names></name><etal/></person-group><article-title>Genomic analysis of the host response to hepatitis C virus infection</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>15669</fpage><lpage>15674</lpage><pub-id pub-id-type="doi">10.1073/pnas.202608199</pub-id><?supplied-pmid 12441396?><pub-id pub-id-type="pmid">12441396</pub-id></element-citation></ref><ref id="B150-ijms-18-02725"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperiali</surname><given-names>F.G.</given-names></name><name><surname>Zaninoni</surname><given-names>A.</given-names></name><name><surname>La Maestra</surname><given-names>L.</given-names></name><name><surname>Tarsia</surname><given-names>P.</given-names></name><name><surname>Blasi</surname><given-names>F.</given-names></name><name><surname>Barcellini</surname><given-names>W.</given-names></name></person-group><article-title>Increased <italic>Mycobacterium tuberculosis</italic> growth in HIV-1-infected human macrophages: Role of tumour necrosis factor-&#x003b1;</article-title><source>Clin. Exp. Immunol.</source><year>2001</year><volume>123</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2001.01481.x</pub-id><?supplied-pmid 11298131?><pub-id pub-id-type="pmid">11298131</pub-id></element-citation></ref><ref id="B151-ijms-18-02725"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>T.M.</given-names></name><name><surname>Chougnet</surname><given-names>C.</given-names></name><name><surname>Schito</surname><given-names>M.</given-names></name><name><surname>Patterson</surname><given-names>B.K.</given-names></name><name><surname>Fox</surname><given-names>C.</given-names></name><name><surname>Shearer</surname><given-names>G.M.</given-names></name><name><surname>Englund</surname><given-names>G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group><article-title>Infection of HIV-1 transgenic mice with <italic>Mycobacterium avium</italic> induces the expression of infectious virus selectively from a Mac-1-positive host cell population</article-title><source>J. Immunol.</source><year>1999</year><volume>163</volume><fpage>1506</fpage><lpage>1515</lpage><?supplied-pmid 10415053?><pub-id pub-id-type="pmid">10415053</pub-id></element-citation></ref></